Paradigm BioCapital Advisors LP 13D/13G Filings for Ambrx Biopharma Inc. (AMAM)

Paradigm BioCapital Advisors LP 13D and 13G filings for Ambrx Biopharma Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-09-25
5:24 pm
Purchase
2023-09-14 13G Ambrx Biopharma Inc.
AMAM
Paradigm BioCapital Advisors LP 25,172,784
5.700%
25,172,784increase
(New Position)
Filing